Mach7 Technologies Ltd (ASX: M7T) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mach7 Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $168.87 million
P/E Ratio 1,428.57
Dividend Yield 0.00%
Shares Outstanding 241.24 million
Earnings per share -0.023
Dividend per share N/A
Year To Date Return -12.66%
Earnings Yield 0.07%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Mach7 Technologies Ltd (ASX: M7T)
    Latest News

    a woman
    Share Market News

    ASX 200 rises 0.4%

    The S&P/ASX 200 Index (ASX:XJO) went up by 0.4% today as resource shares such as Rio Tinto Limited (ASX:RIO) pulled…

    Read more »

    asx medical share price represented by x-ray or people shaking hands
    Share Market News

    Here's why the Mach7 (ASX:M7T) share price just reached a multi-year high

    The Mach7 Technologies Ltd (ASX: M7T) share price is soaring today after the company announced an amended contract with Adventist…

    Read more »

    hand on touch screen lit up by a share price chart moving higher
    Share Gainers

    Why IDP Education, Lake Resources, Mach7, & Tyro shares are shooting higher

    Lake Resources N.L. (ASX:LKE) and Mach7 Technologies Ltd (ASX:M7T) shares are two of four shooting higher on Monday...

    Read more »

    Share Gainers

    Why the Mach7 (ASX:M7T) share price is surging 8% higher today

    The Mach7 Technologies Ltd (ASX:M7T) share price is surging higher on Thursday after releasing its second quarter update...

    Read more »

    two hands wearing medical gloves make the shape of a heart, indicating the best healthcare shares on the ASX market
    ⏸️ ASX Shares

    2 fantastic ASX healthcare shares to buy

    Pro Medicus Limited (ASX:PME) and this ASX healthcare share could be top options for investors looking for exposure to the sector...

    Read more »

    A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
    ⏸️ ASX Shares

    Fundie names 5 ASX shares with good growth prospects

    The 5 ASX shares in this article are rated as good stock ideas by fund manager Clime Capital (ASX:CAM) such…

    Read more »

    miniature figure of man standing in front of piles of coins
    ⏸️ ASX Shares

    Wilson Asset Management thinks these 2 small cap ASX shares are a buy

    Fund manager Wilson Asset Management (WAM) thinks that these 2 small cap ASX shares are worth a buy, 1 is…

    Read more »

    ASX share price on watch represented by surprised man with binoculars
    Speculative

    2 growing small cap ASX shares to watch in 2021

    MyDeal.com.au Limited (ASX:MYD) and this ASX small cap share could be worth watching closely in 2021...

    Read more »

    ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,
    Speculative

    2 small cap ASX healthcare shares to watch

    Could these ASX small cap healthcare shares follow in the footsteps of CSL Limited (ASX:CSL)?

    Read more »

    Woman in pink sweater lying on dock with binoculars to her eyes
    Speculative

    2 exciting small cap ASX shares to watch closely in 2021

    It will be worth watching Mach7 Technologies Ltd (ASX:M7T) and this ASX small cap share closely in 2021. Here's why...

    Read more »

    high share price
    Share Gainers

    Why the Mach7 (M7T) share price is closing in on a record high today

    The Mach7 Technologies Ltd (ASX:M7T) share price is pushing higher on Monday after the release of its AGM update...

    Read more »

    A compass with the word opportunities is shown in black and blue representing a broker upgrade on the EML share price
    Speculative

    2 exciting small cap ASX shares to buy

    Audinate Group Limited (ASX:AD8) and this ASX small cap share have been tipped as ones to buy...

    Read more »

    Frequently Asked Questions

    No,  this ASX small-cap share has never paid dividends.

    Mach7 Technologies has been listed on the ASX since 30 November 2005.

    M7T ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mach7 Technologies Ltd

    Mach7 Technologies Ltd (ASX: M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. Its systems create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. This allows healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence.

    Mach7 has more than 150 customers in 15 countries and derives a majority of its revenue from North America.

    M7T Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Mar 2024 $0.70 $0.01 1.45% 109,249 $0.70 $0.70 $0.68
    26 Mar 2024 $0.69 $0.00 0.00% 287,077 $0.69 $0.69 $0.68
    25 Mar 2024 $0.69 $0.01 1.47% 255,729 $0.67 $0.69 $0.66
    22 Mar 2024 $0.68 $0.00 0.00% 80,129 $0.68 $0.68 $0.67
    21 Mar 2024 $0.68 $0.01 1.49% 118,117 $0.67 $0.68 $0.67
    20 Mar 2024 $0.67 $-0.01 -1.47% 498,510 $0.70 $0.70 $0.65
    19 Mar 2024 $0.68 $-0.02 -2.86% 122,226 $0.70 $0.71 $0.68
    18 Mar 2024 $0.70 $-0.01 -1.42% 31,144 $0.72 $0.72 $0.70
    15 Mar 2024 $0.71 $0.01 1.43% 14,976 $0.70 $0.71 $0.70
    14 Mar 2024 $0.70 $-0.01 -1.41% 195,707 $0.70 $0.71 $0.70
    13 Mar 2024 $0.71 $0.01 1.42% 164,791 $0.70 $0.73 $0.70
    12 Mar 2024 $0.71 $0.00 0.00% 1,545,723 $0.71 $0.71 $0.70
    11 Mar 2024 $0.71 $-0.01 -1.41% 17,014 $0.72 $0.72 $0.70
    08 Mar 2024 $0.71 $0.01 1.42% 190,521 $0.70 $0.71 $0.69
    07 Mar 2024 $0.71 $0.00 0.00% 161,936 $0.71 $0.72 $0.69
    06 Mar 2024 $0.71 $-0.02 -2.78% 79,288 $0.72 $0.72 $0.71
    05 Mar 2024 $0.72 $0.02 2.84% 317,497 $0.70 $0.73 $0.69
    04 Mar 2024 $0.71 $0.01 1.44% 189,799 $0.69 $0.71 $0.68
    01 Mar 2024 $0.70 $0.03 4.51% 28,694 $0.68 $0.70 $0.68
    29 Feb 2024 $0.67 $-0.01 -1.49% 530,079 $0.68 $0.71 $0.67
    28 Feb 2024 $0.67 $-0.01 -1.47% 89,702 $0.68 $0.68 $0.67
    27 Feb 2024 $0.68 $-0.02 -2.86% 248,698 $0.70 $0.71 $0.68

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    01 Dec 2023 Eliot Siegel Issued 25,000 $18,125
    Issue of options.
    01 Dec 2023 Robert Bazzani Issued 25,000 $18,125
    Issue of options.
    23 Nov 2023 Mike Lampron Issued 700,000 $434,000
    Issue of securities. 1,825,185 Performance Rights
    17 Nov 2023 Mike Lampron Issued 325,000 $234,000
    Issue of securities.
    01 Nov 2023 Eliot Siegel Buy 225,000 $54,900
    Exercise of options.
    01 Nov 2023 Eliot Siegel Exercise 225,000 $54,900
    Exercise of options. As per announcement on 06-11-2023
    21 Sep 2023 Mike Lampron Sell 89,810 $65,381
    As advised by the company. Disposal of shares under sell-to-cover arrangement
    21 Sep 2023 Mike Lampron Issued 350,000 $255,500
    Exercise of options.
    21 Sep 2023 Mike Lampron Exercise 350,000 $255,500
    Exercise of options. As per announcement on 22-09-2023
    29 Jun 2023 David Chambers Exercise 225,000 $54,900
    Exercise of options.
    29 Jun 2023 David Chambers Buy 225,000 $54,900
    Exercise of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Eliot L Siegel Non-Executive Director Aug 2018
    Dr Siegel is known thought leader in the world of radiology and imaging informatics and artificial intelligence applications in medicine. He is currently Professor and Vice Chair of information systems at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and the Chief of Radiology and Nuclear Medicine for the Veterans Affairs Maryland Healthcare System, both in Baltimore, MD as well as adjunct professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the World. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited six books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a broad range of topics involving the use of computers in medicine and artificial intelligence. Dr. Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honored as a fellow in that organisation as well as the American College of Radiology. He is also a Board member of Carestream Health, a billion-dollar global company in digital radiography and computed radiography systems and serves on numerous advisory boards in medical imaging.He is Member of Risk Committee.
    Mr Mike Lampron Chief Operating OfficerChief Executive OfficerManaging Director Mar 2019
    Mr Lampron is the CEO of Mach7 Technologies. With over 20 years of experience in business and operational management for Healthcare IT companies, Mike brings a experience ranging from private start-up organisations as well as established companies such as IBM and GE. Mike was previously the Chief Executive Officer for a National Teleradiology Company and has a proven ability to drive results through a combination of astute analysis, innovative execution and crossfunctional teamwork. Michael is responsible for our customers' success while driving excellence throughout Mach7.
    Mr Robert John Bazzani Non-Executive Director Jan 2020
    Mr Bazzani spent 20 years with the global consulting firm KPMG, where he rose to the top and served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia's Enterprise Division and National Managing Partner for KPMG's M&A Division. Whilst in these roles, Rob was a member of KPMG's National Executive Committee (NEC), which oversees and is responsible for the Firm's turnover, strategic decision making, profitability and operations. Rob has a demonstrated track record of leading and growing scale and complex businesses. He has played a role in advising clients (public, private, and global subsidiaries) on commercial maters, public transitions, corporate governance, investment banking and law, M&A and has engaged with Government and Regulators. With experience in corporate advisory, Rob has deep commercial and industry knowledge across financial services, asset and wealth management, technology, property, insurances and consumer & industrial markets. He is Chair of Risk Committee.
    Mr Peter Gundy Non-Executive Director Nov 2023
    --
    Ms Rebecca Thompson Non-Executive Director Nov 2023
    --
    Mr Tony Panther Company Secretary Feb 2023
    -
    Tony Panther Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Sandhurst Trustees Ltd (Jmfg Consol A/C) 34,943,767 14.54%
    National Nominees Limited 33,728,744 14.04%
    J P Morgan Nominees Australia Pty Limited 26,127,926 10.87%
    Hsbc Custody Nominees (Australia) Limited 12,558,036 5.23%
    Citicorp Nominees Pty Limited 9,220,511 3.84%
    Lawn Views Pty Ltd (Angela Williams Family A/C) 6,363,394 2.65%
    Pt Dwi Satrya Utama 4,392,959 1.83%
    UBS Nominees Pty Ltd 4,022,984 1.67%
    Perco Group Pty Ltd (F S P A/C) 4,000,000 1.66%
    Padmalwar Prakash 3,569,921 1.49%
    Chew & Partners (Import & Export) Pte Ltd 2,900,074 1.21%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 2,639,345 1.10%
    Albert Liong Pak-Fai 2,044,189 0.85%
    Bpnt Pty Ltd (The Heaney Family Super A/C) 2,000,000 0.83%
    Bpnt Pty Ltd (The Heaney Family Sf A/C) 1,921,218 0.80%
    Microequities Asset Management Pty Ltd (Microeqts Nanocap No 11 A/C) 1,751,702 0.73%
    Supernatural Super Pty Ltd (The Supernatural Super A/C) 1,684,000 0.70%
    Mr Ravindran Krishnan 1,636,422 0.68%
    Bnp Paribas Noms Pty Ltd (Drp) 1,467,677 0.61%
    Ty Webb Pty Ltd (Ty Webb A/C) 1,339,444 0.56%

    Profile

    since

    Note